Program: Wednesday, March 3
Sunday, February 28
Monday, March 1
Tuesday, March 2
Wednesday, March 3
- Keynote Session 5
- Spotlight Sessions 5-6
- Rewiring T Cell Signaling: Synthetic Biology for Discovery and Therapy
- Panel Discussion – Advancing Cancer Immunotherapy – From Mechanisms to Clinical Impact
- Major Symposia 9-10
- Rewriting T Cell Fate: Epigenetic Control of Stemness and Exhaustion
- Spatio-Temporal Determinants of Anti-Tumour Immune Responses
* – Short talk selected from proffered abstracts
Wednesday, March 3
Breakfast with mentoring roundtables
7-8:30 a.m. | Diamond Ballroom 1-3
Keynote Session 5
8:30-9:45 a.m. | Diamond Ballroom 5-10
- 8:30 a.m. | Keynote Speaker
Carl H. June, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania - 8:55 a.m. | Keynote Speaker
Ton N. Schumacher, Netherlands Cancer Institute, Amsterdam, Netherlands - 9:20 a.m. | Discussion / Q&A
Break
9:45-10 a.m. | Diamond Ballroom Foyer
Spotlight Sessions 5-6
10-10:55 a.m.
Spotlight Session 5: Rewiring T Cell Signaling: Synthetic Biology for Discovery and Therapy
Diamond Ballroom 5-10
Session Chair: Anusha Kalbasi, Stanford University, Stanford, California
- 10 a.m. | Anusha Kalbasi
- 10:20 a.m. | Speaker to be announced
- 10:40 a.m. | Discussion / Q&A
Spotlight Session 6: Panel Discussion – Advancing Cancer Immunotherapy – From Mechanisms to Clinical Impact
Diamond Ballroom 4
Break
10:55-11:15 a.m. | Diamond Ballroom Foyer
Major Symposia 9-10
11:15 a.m.-12:45 p.m.
Major Symposium 9: Rewriting T Cell Fate: Epigenetic Control of Stemness and Exhaustion
Diamond Ballroom 5-10
Session Chair: Luca Gattinoni, Leibniz Institute for Immunotherapy, Regensburg, Germany
- 11:15 a.m. | Luca Gattinoni
- 11:35 a.m. | Evan W. Weber, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
- 11:55 a.m. | Speaker to be announced
- 12:15 p.m. | Discussion / Q&A
Major Symposium 10: Spatio-Temporal Determinants of Anti-Tumour Immune Responses
Diamond Ballroom 4
Closing remarks
12:45 p.m. | Diamond Ballroom 5-10